Stereotactic body radiation therapy for low and intermediate risk prostate cancer—Results from a multi-institutional clinical trial

This publication has 35 references indexed in Scilit:

• Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results
  Radiation Oncology, 2013
• Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
  Radiation Oncology, 2013
• Prostate alpha/beta revisited – an analysis of clinical results from 14 168 patients
  Acta Oncologica, 2012
• Stereotactic body radiation therapy for the primary treatment of localized prostate cancer
  Journal of Radiation Oncology, 2012
• Improved Clinical Outcomes With High-Dose Image Guided Radiotherapy Compared With Non-IGRT for the Treatment of Clinically Localized Prostate Cancer
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
• Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan
  Radiation Oncology, 2012
• Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial
  Trials, 2011
• 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
• Phase I Dose-Escalation Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
  Journal of Clinical Oncology, 2011
• Sexual Function Before and After Radical Retropubic Prostatectomy: A Systematic Review of Prognostic Indicators for a Successful Outcome
  European Urology, 2006